Evaxion and Afrigen Biologics to develop mRNA vaccine for gonorrhoea
The collaboration will utilise Evaxion’s EDEN-discovered antigen targets
Read More
Tag: EDEN
Evaxion validates its infectious disease AI vaccine platform
The platform identifies antigens to fight against bacterial infectious disease
Read More
- RougeTx launches with $58 million series A financing for HHT therapy
- Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease
- Bespak and SNBL agree global access deal for FDA‑approved nasal device
- NEMLUVIO data show sustained three‑year responses in atopic dermatitis
- SMC accepts AQUIPTA for eligible migraine patients in Scotland
